Endocrine dysfunctions in patients treated for brain tumors: incidence and guidelines for management.
Endocrine alterations are frequently found in patients undergoing treatment for CNS tumors. Careful follow-up aimed at the early detection of recurrences, with life-long monitor of hypothalamus-pituitary (HP) function, will also reveal any endocrine dysfunctions; indeed, their appropriate diagnosis and treatment may determine a significant improvement in the quality of life of these patients.
Brandes
A A
AA
Department of Medical Oncology, Gastroenterological Sciences, Azienda Ospedale Università, Padova, Italy. brandes@ux1.unipd.it
Pasetto
L M
LM
Lumachi
F
F
Monfardini
S
S
D001932:Brain Neoplasms / Q000453:epidemiology* / Q000628:therapy; D004700:Endocrine System Diseases / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D017410:Practice Guidelines as Topic